REQUEST A DEMO
Total
USD $0.00
Search more companies

Piluss Clon Sas (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Piluss Clon Sas Profile Updated: May 21, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Piluss Clon Sas is based in Colombia, with the head office in Cali. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on September 10, 2019. 5 (2024) employees currently work for Piluss Clon Sas. There was a net sales revenue increase of 69.82% reported in Piluss Clon Sas’s latest financial highlights for 2023. There was a total growth of 23.27% in Piluss Clon Sas’s total assets over the same period. In, 2023, the company’s net profit margin increased by 14.3%.

Headquarters
Kr 2 # 44 - 60
Cali; Valle del Cauca;

Contact Details: Purchase the Piluss Clon Sas report to view the information.

Basic Information
Total Employees:
Purchase the Piluss Clon Sas report to view the information.
Outstanding Shares:
Purchase the Piluss Clon Sas report to view the information.
Incorporation Date:
September 10, 2019
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Piluss Clon Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
69.82%
Total operating revenue
69.82%
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
44.5%
Total assets
23.27%
Total equity
47.72%
Operating Profit Margin (ROS)
N/A
Net Profit Margin
14.3%
Return on Equity (ROE)
15.84%
Quick Ratio
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?